Kyn Biosciences Inc. is a seed and series A-stage investment group that leverages expertise in technology, finance, governance, operations, and regulatory frameworks to identify global investment opportunities within the biosciences domain. Kyn’s areas of interest include, but are not limited to, novel extraction methodologies, pharmaceutical applications, delivery systems, experimental or research platforms, and clinical trials.